About Energenesis Biomedical
Energenesis Biomedical is a publicly listed company based in Neihu (Taiwan) founded in 2012. It focuses on developing novel biomedicine treatments for various diseases. It operates on a B2B model. Its focus areas include Biotechnology, Biomedicine and Drug Development.
Company details
Energenesis Biomedical, based in Neihu, focuses on providing healthcare solutions, advancing biotech innovations, biomedicine, and drug development. Focuses on developing novel biomedicine treatments for various diseases. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Neihu, Taiwan
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website energenesis-biomedical.com
- Legal Name Energenesis Biomedical Co., Ltd.
- Annual Revenue$7.67 M-0.97as on Dec 31, 2025
- Net Profit-$258.4 M-11.82as on Dec 31, 2025
- EBITDA-$252.7 M-8.75as on Dec 31, 2025
IPO & Listings of Energenesis Biomedical
Energenesis Biomedical is a publicly listed company on the TWSE with ticker symbol 6657 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date12 Jun 2023
- Listed onTWSE: 6657
- Listed entityEnergenesis Biomedical Co., Ltd.
- Exchange sectorHealth technology
- ISINTW0006657000
- Share price33.05 TWD (-0.6% on the day) · 2026-10-14
- Market capitalisation2,952,865,955.00 TWD
- EPS (diluted, trailing year)-3.39 TWD
- Volume (last session)92,590
Financials of Energenesis Biomedical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 7.7M TWD | -258.4M TWD | -252.7M TWD |
| 2024 | 7.8M TWD | -231.1M TWD | -232.4M TWD |
| 2023 | 7.2M TWD | -260.4M TWD | -238.0M TWD |
| 2022 | 7.3M TWD | -265.7M TWD | -247.2M TWD |
| 2021 | 7.5M TWD | -120.2M TWD | -99.2M TWD |
Detailed financial statements for Energenesis Biomedical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Energenesis Biomedical
Websites that share an audience with Energenesis Biomedical (energenesis-biomedical.com).
Websites whose visitors overlap most with Energenesis Biomedical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| onenessbio.com | 34% | 9.2K | #2,338,055 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Energenesis Biomedical
Complete news archive for Energenesis Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Energenesis Biomedical
Energenesis Biomedical was founded in 2012.
Energenesis Biomedical is headquartered in Neihu, Taiwan. It is registered at Neihu, Taipei, Taiwan.
Energenesis Biomedical, based in Neihu, focuses on providing healthcare solutions, advancing biotech innovations, biomedicine, and drug development. Focuses on developing novel biomedicine treatments for various diseases. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Yes, Energenesis Biomedical is publicly traded on TWSE under the ticker symbol 6657.